The aims of the present study were to implement a microbead-based 'spoligotyping' technique and to evaluate improvements by the addition of a panel of 25 extra spacers that we expected to provide an increased resolution on principal genetic group 1 (PGG 1) strains. We confirmed the high sensitivity and reproducibility of the classical technique using the 43 spacer panel and we obtained perfect agreement between the membrane-based and the microbead-based techniques. We further demonstrated an increase in the discriminative power of an extended 68 spacer format for differentiation of PGG 1 clinical isolates, in particular for the East AfricanIndian clade. Finally, we define a limited yet highly informative reduced 10 spacer panel set which could offer a more cost-effective option for implementation in resource-limited countries and that could decrease the need for additional VNTR (variable number of tandem repeats) genotyping work in molecular epidemiological studies. We also present an economic analysis comparing membrane-based and microbead-based techniques.
INTRODUCTION
The current global plan for tuberculosis (TB) control suggests that it will be difficult to eradicate the disease by 2050 (Dye & Williams, 2008) . This issue is particularly relevant to large nations with high TB infection rates, such as Brazil, Russia, India, China and Mexico, but it is also relevant to resource-poor countries in Asia and Africa, which are facing the combined threat of human immunodeficiency virus and TB (Uplekar & Lonnroth, 2007) . TB transmission chains may be interrupted in resource-poor countries by improvements in public health programmes, medical diagnostics facilities and provision of adequate drug treatment (Dye & Williams, 2008) . The Millenium Development Goals of the United Nations Organization has called for the detection of 70 % of active cases through the development of rapid diagnostics methods, and the attainment of 80 % cure rates, through means such as expansion of the Directly Observed Treatment of Short Course (DOTS+) programme. However, the expanding threat of multidrug resistant (MDR) TB (resistance to isoniazid and rifampicin) and now of extremely drug resistant (XDR) TB , which is defined as a MDR-TB that is resistant to any fluoroquinolones plus at least one of the three injectable second-line drugs (amikacin, capreomycin, kanamycin) (Manissero & Fernandez de la Hoz, 2006) , has made the implementation of public health measures, and molecular epidemiological investigations using rapid and high throughput molecular methods, a crucial priority to achieve these goals.
TB is caused by the Mycobacterium tuberculosis complex (MTC), which can be defined genetically as a single bacterial species within the order Actinomycetales and encompasses several ecotypes or subspecies that include M. tuberculosis, Mycobacterium bovis, Mycobacterium africanum, 'Mycobacterium canettii', M. microti, M. caprae and Mycobacterium pinipedii Smith et al., 2006) . Rapid molecular diagnostics methods have been developed during the two last decades; however, these methods have been slow to be implemented worldwide (Drobniewski et al., 2003) . Spoligotyping, comprises a PCR-based reverse line blot hybridization method that assesses the genetic diversity of the direct repeat (DR) locus (Kamerbeek et al., 1997) . The DR locus spans up to 5 kb and represents 0.1 % of the MTC genome. It is a member of the clustered regularly interspaced palindromic repeats (CRISPR) loci genetic family and is found in all Archaea and around 40 % of Eubacteria (Jansen et al., 2002) . CRISPR loci are believed to have a functional role against bacteriophage challenge, and at the evolutionary genetics level contain remnants and 'memories' of previous bacteriophage encounters. Due to their genetic polymorphisms, CRISPR loci may be excellent epidemiological markers (Sorek et al., 2008) .
The MTC DR locus is made up of a limited number of direct variable repeats (DVRs), each repeat is made up of a conserved 36 bp sequence (the DR) and of a variable 35-41 bp sequence (the spacer). A total of 43 spacers were initially chosen, comprising 6 spacers from M. bovis BCG and 37 spacers from the M. tuberculosis H37Rv genomes (Groenen et al., 1993; Kamerbeek et al., 1997) . Only 10 of these spacers are required to differentiate many of the MTC (Sebban et al., 2002) and this set could be useful as a preliminary 'fast lane' screen. Spoligotyping has been found to be congruent with other molecular techniques, such as multilocus sequence typing (Baker et al., 2004) , single nucleotide polymorphism (SNPs) and large sequence polymorphism analysis (Filliol et al., 2006; Gagneux & Small, 2007; Gutacker et al., 2006) . However, for more indepth molecular epidemiological analysis, higher discriminatory genotyping techniques are necessary. These rely on mini-satellite type sequences known as MIRUs (mycobacterial interspaced repeat units) or VNTRs (variable number of tandem repeats). A 24 locus VNTR typing scheme was adopted widely (Supply et al., 2006) ; it was found to be much more discriminatory than spoligotyping, but not fully concordant, hence there is still a need to perform the two techniques to obtain optimal discrimination. Thus, as spoligotypes are considered both as phylogenetic and epidemiological markers (Asiimwe et al., 2008; Sola et al., 2001; Tanaka & Francis, 2006; Valcheva et al., 2008) , extensive spoligotype databases have proved useful in determining and cataloguing worldwide MTC genetic diversity (Brudey et al., 2006) . However, concerns have been raised by some investigators about the potential consequences of suboptimal spoligotyping results, or interpretations of results, on the quality of international databases.
Multiplexing is an efficient way to increase the throughput and efficiency of genotyping results and many recent techniques, such as multiple ligation-mediated assays, are showing promise in this area (Bergval et al., 2008) . A DNA chip-based spoligotyping method for the strain identification of M. tuberculosis isolates has also been recently developed (Song et al., 2007) . All these techniques are particularly well suited to SNP analysis and may be used to assess between 100 to 1000 probes in a single tube (Hardenbol et al., 2003) . However, at the lower range of the analysis (50-200 probes), macro-arrays and more recently the suspension microarray format are proving sufficiently powerful and economical genotyping methods (Kaufhold et al., 1994; Goguet de la Salmoniere et al., 2004; Dunbar et al., 2003) .
A single study by the Centers for Disease Control and Prevention, USA, evaluated the possibility of transferring spoligotyping to a multiplex microbead-based suspension array format (Cowan et al., 2004) . However, economical restrictions have meant that this has not yet been widely implemented. Yet as the cost of medical diagnosis devices drop, and newer and even more innovative systems will be developed, this versatile microbead suspension format could prove useful even in resource-limited settings because: (i) it is a simple and powerful multianalyte system, (ii) the use of the microspheres is easy with a 96-well microplate format, (iii) it is flexible and has the opportunity to include new or customized probes, (iv) it has high throughput, (v) it is a time-saving technique, (vi) it increases the quality of results. Such a molecular diagnostic and genotyping device could be fully dedicated to public health-oriented MTC genotyping projects and would provide effective support for epidemiological studies in national TB reference centres, and other TB diagnostic laboratories that have the capacity for mycobacterial cultures and DNA preparation.
In this article, we describe the implementation of and improvements to the spoligotyping technique in different formats, including suggestions for an increased discrimination format or simplifications to create a reduced costeffective form suitable for a wide range of settings.
METHODS
Chemicals, buffers, microbeads and oligonucleotides. N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide (EDC) was used for oligonucleotide-microbead coupling (Pierce Chemical) in 0.1 M MES buffer solution, pH 4.5 (Sigma-Aldrich). Hybridization solutions of 1.56 and 16 TMAC (tetra-methyl ammonium chloride) were prepared using 5 M TMAC (Sigma-Aldrich), 20 % sarkosyl (sodium lauroylsarcosinate), Tris/HCl and EDTA, and were prepared as described by Cowan et al. (2004) . Oligonucleotides (25mers) were modified (van Embden et al., 2000) from described sequences (Kamerbeek et al., 1997) (Table 1) . Panel 1 used a standardized 43 spacer format (Sebban et al., 2002) . Panel 2 (25 more spacers) was chosen to improve the discrimination for the MTC M. africanum subspecies and for the East African-Indian (EAI) clade (van Embden et al., 2000) . The 10 spacers of panel 3 included spacer number 7, 9, 18, 22, 29, 31, 32, 33, 34 and 43 (Kamerbeek nomenclature) , and were chosen based on previous bioinformatics results (Sebban et al., 2002) . Primers 59-biotinylated DRa (GGTTTTGGGTCTGACGAC) and DRb (CCGAGAGGGGACGGAAAC) were used for the spoligotyping PCR. All capture oligonucleotides (Eurogentec) were supplied with a 59 terminal amino group modification using a 12 carbon spacer linker to increase the free space between the microspheres and the oligonucleotides for a better hybridization.
Microbead coupling. Luminex xMap microbeads (L100-C101 to L100-C168) were resuspended by vortexing (20 s) and sonication (20 s). Microbeads (2.5 million) were transferred to an Eppendorf Protein LoBind tube and pelleted at 8000 g for 1-2 min. The supernatant was discarded and the pellet was resuspended in 25 ml 0.1 M MES buffer (pH55.4). Oligonucleotides were suspended in ultrapure water at 1 mM and 100 pmol oligonucleotide capture probe previously diluted to 0.1 mM was added to the microbeads. A fresh EDC solution (10 mg ml 21 ) was prepared and 1.25 ml was added to each Eppendorf tube. Incubation was carried out in the dark at room temperature for 30 min. Subsequently 1.25 ml EDC was added to each tube and incubation at room temperature was carried out in the dark for a further 30 min. The microbeads were then washed with 0.5 ml Tween 20 (0.02 %) followed by 0.5 ml SDS (0.1 %), and then resuspended in 50 ml (16) TE (10 mM Tris, 1 mM EDTA, pH 8) with vortexing and sonication. Coupled microbeads were stored in the dark at 4 uC until required. A mixture of appropriate beads, depending on the assay, was prepared by combining equal volumes of each selected coupled set. Microbead concentration was checked by haemocytometer. Bead coupling efficiency was checked for the first designed capture probe using hybridization with a biotinylated-antisense detection probe followed by the multianalyte dual-laser detection.
Spoligotyping PCR protocol. PCR (25 ml total) was performed for 20 cycles (Kamerbeek et al., 1997) using thermolysates as samples. This was expected to generate 10 6 amplification copies of each spacer for each tube.
Microbead-based multianalyte two-laser system: principle, hardware and software. The system (Luminex 200) is made up of three components: an analyzer/reader, a microplate handler and a sheath-fluid delivery component. The software used was Luminex version 2.3. The device uses oligonucleotide-coupled microspheres (diameter 5.4 mm) as support, with oligonucleotide capture probes that have been previously covalently linked to the microspheres. If, within a PCR product, the target of the capture probe is present, it will hybridize to the microbead surface. Each set of microbeads is characterized by a combination of two dyes (one red and one near infrared) so that each set has a unique spectral address. Beads are presented individually to detection lasers through a quartz cuvette. A 635 nm red laser excites the two dyes in each bead and identifies which set it belongs to. A 532 nm green laser is the reporter laser that excites the fluorochromes bound to the PCR product hybridized to the beads and provides quantification.
Hybridization. A defined microsphere mixture was prepared by addition of each set of stocked beads in 1.56 TMAC hybridization buffer to a final concentration of approximately 150 microspheres ml 21 for each set. For hybridization, we added 2 ml PCR product into 33 ml microsphere mixture. After a denaturation at 95 uC for 5 min, incubation was done at 52 uC for 15 min. Plates were centrifuged at 2250 g for 3 min and half of the supernatant (30 ml approximately) was replaced with the same amount of 16 TE. A reporter mix (25 ml) was prepared by adding 4 ml streptavidin-R-phycoerythrin (1 mg ml 21 ) (Molecular Probes) to 996 ml 16 TMAC hybridization buffer in the plates. After a final incubation again at 52 uC for 5 min, mixtures were analysed by the microplate reader as suggested in the user's manual.
Data analysis. The distribution of the values obtained for each spacer was determined, as described by Cowan et al. (2004) , as bimodal. A cut-off value was initially chosen by eye for each spacer. A mean negative value and mean positive value were then calculated and the signal to noise ratio (S : N) derived from the ratio of the two means. We also extrapolated a mean control value and derived a simple calculation linking the cut-off value and the mean negatives.
Statistical analysis. The Hunter and Gaston index (HGDI) was computed to show the superiority of the 68 spacers versus 43 spacers technique for the EAI and M. bovis clades (Hunter & Gaston, 1988) .
Mycobacterial isolates, origin, DNA extraction. Two independent sets of 50 DNA extractions were obtained from MTC clinical isolates from the Bichat Claude Bernard Hospital, Paris (R. Ruimy, unpublished results). Both sets had been previously genotyped by spoligotyping using commercial membranes (Isogen Biosciences). One set was representative of the overall genetic diversity of M. tuberculosis found in Paris; the second was selected to include more M. africanum and EAI isolates, and other less defined principal genetic group (PGG) 1 and PGG 2 organisms (Sreevatsan et al., 1997) based on their spoligotyping signatures determined by Soini et al. (2000) . A further set of DNA samples extracted from a set of bovine clinical isolates from the French Food Safety Agency Laboratory for bovine tuberculosis (Agence Française de Sécurité Sanitaire des Aliments, Maisons-Alfort, France) (n5234) and a last set obtained from human clinical isolates from the Institut Pasteur du Cambodge (n5118) were also tested using the 68 spacer set format. Ten more DNA samples extracted from as many clinical isolates from a previous molecular epidemiological study performed in Albania (Tafaj et al., 2009) were also included on a reduced spacer panel (panel 3). All DNAs were extracted using a thermolysate method (three cycles of freeze-thaw followed by centrifugation and removal of cell pellets). DNA samples were stored at 220 uC until use.
RESULTS AND DISCUSSION
Development of the classical 43 spacers format assay (panel 1)
We initially tested the microbead-based multianalyte duallaser device with a standard spoligotyping format by coupling 43 oligonucleotide spacers to microbeads. A total of 50 MTC DNAs from clinical isolates obtained from Bichat Claude Bernard Hospital, Paris, were blinded and genotyped using both microbead-based and membranebased formats ( , 2000) and that the deletion in DR16 could decrease the relative amount of spacer 15 amplification, which ultimately lead to a lower S : N ratio. Nevertheless, despite the lower signal we could clearly distinguish between positive and negative values confirming the power of the microbead-based technique. We also observed a low S : N for spacer 15 on beads as previously seen in membrane-based assays. The addition of a washing step increased S : N for all spacers (see experiment 2 compared to experiment 1 in Table 2 ). Additional typing experiments confirmed that the cut-off value remained constant with each set of beads and that the method was fully reproducible (H37Rv and M. bovis BCG, and a negative control, were systematically included).
Obtaining good results using the classical membrane-based spoligotyping assay critically depends on the quality of a membrane. Although theoretically reusable up to 10-20 times, commercial membranes tend to provide lesser quality results after 6-8 uses and this phenomenon was responsible of some of the discrepancies we observed initially. In this work, these instances were few and were all solved after retesting using a new membrane. It is also clear that coupling efficiency (i.e. between the beads and the probes) may also influence the quality of the results. However, we did not experience problems in this regard. We nevertheless advise recalculation of cut-off values for individual batches of coupled beads.
RFI values of all spacers for some samples were lower than those obtained for other samples. This result was most likely caused by the use of inferior quality DNA leading to suboptimal PCR amplification as in this study we used DNA extracted from thermolysates, which are known to often generate low-quality samples. Yet even using these suboptimal extractions the discriminative power resulting from this procedure was high, suggesting that even with unpurified (low DNA concentration) thermolysates the method can be considered as highly robust. Recent results on a much larger set of samples (more than 4000) showed that cetyl-trimethylammonium-extracted DNA gave higher S : N than thermolysate DNA, further simplifying analysis (data not shown).
Extended spoligotyping using 25 more spacers (panel 2)
A subset of PGG 1 isolates, as defined by Sreevatsan et al. (1997) and Soini et al. (2000) , from the first set of 50 DNAs, combined with a further set that included a majority of PGG 1 clinical isolates (n5402 total), was chosen to test an improved spoligotyping format. become a suitable method to run population-based molecular epidemiological studies in South-East Asia where the EAI clade is prevalent. Our sampling on M. africanum is currently too low to conclude on the superiority of the 68 versus 43 spoligotyping format.
The introduction of 25 additional spacers, derived from M. bovis and M. tuberculosis sequences (Beggs et al., 1996) , provided the greatest discriminatory power so far achieved within the MTC complex, with the exception of the 'M. canettii' subspecies whose typing would require 26 more spacers (van Embden et al., 2000) . In previous works, we and other investigators have suggested that the introduction of 25 new spacers could improve genotyping, especially for large animal and human-adapted MTC PGG 1 subspecies (Brudey et al., 2004; van der Zanden et al., 2002; Javed et al., 2007) . In this study, we confirm that this improvement is significant for the study of the clinical isolates belonging to the EAI clade that is prevalent in South-East Asia.
Development of a simplified 10 spacers format assay (panel 3)
Other genetic diversity studies on MTC using IS6110-RFLP, VNTR, SNPs or region of differences diversity studies have identified a phylogeographical population structure in this monomorphic bacterial species (Baker et al., 2004; Dos Vultos et al., 2008; Gagneux & Small, 2007; Gutacker et al., 2006; Kremer et al., 1999; Sola et al., 2003; van Embden et al., 1993) . A previous bioinformatics study has shown that a limited set of spoligotype spacers (n510, spacers number 7, 9, 18, 22, 29, 31, 32, 33, 34 and 43) could be sufficient to discriminate between the most prevalent MTC phylogeographical types (Sebban et al., 2002) . Using these spacers we also implemented a simplified microbeadbased spoligotyping assay format, which could be used as a relatively inexpensive 'first screen' genotyping technique for MTC. This assay could also be used as an external quality control for laboratories still working with membrane-based spoligotyping, or as a first step toward further multiplexing. Other markers such as rifampicin-resistance mutations (rpoB) could be included in these assays. The use of a 10 spacers assay (panel 3) would naturally be cheaper, and still remain an informative assay that could be suited to resource-limited countries. Improving the capacity and transfer of rapid molecular diagnostics methods, whilst decreasing prices of emerging technologies, are undoubtedly desirable objectives towards good public-health strategies and achieving a more sustainable decrease in preventable deaths caused by poverty-related infectious diseases.
Comparison of the cost/output ratio of the microsphere-based versus the membrane-based assay for spoligotyping
Spoligotyping, either using a microbead-based multianalyte genotyping platform or membrane-based, is a rapid diagnostic test most suitable for studying TB disease in high-burden countries. One important parameter for technology transfer, especially for resource-poor or middle-income countries, will be the cost/output ratio needed to introduce the new technique (microbead-based high throughput) compared to the established one (membranebased low throughput). We thus evaluated the relative costs of material, reagents and staff required to genotype 5000 samples by the two techniques (based on a 'standardized' 43 spacers format). The results (Table 4) showed that running spoligotyping through a high throughput multianalyte hybridization device would be 30-40 % more expensive than a standard membrane-based technique. The throughput is at least 4-8 times higher using the microbead-based rather than the membranebased approach. It also improves the global quality in TB genotyping by (i) introducing standardized cut-off values thus improving standardization of spoligotyping, (ii) theoretically helping to discover new SNPs in CRISPR loci, (iii) increasing the potential use of newly discovered spacers (Brudey et al., 2004; van der Zanden et al., 2002; van Embden et al., 2000) . In countries where TB outbreaks are largely linked to M. africanum, the EAI clade or even the CAS clade, i.e. within Africa and the Indian subcontinent and Asia (Ahmed & Leblebicioglu, 2006) , this is particularly relevant.
The microbead-based format allows a digital-numerical data output less prone to interpretation errors. This output is also more amenable to being managed through large international databases that can be curated for genotyping errors.
The advent of molecular epidemiological techniques using polymorphic repeated DNA markers has improved ways to investigate TB outbreaks (van Soolingen, 2001 ). In particular they have been used to demonstrate to clinicians, epidemiologists and public health investigators that recent TB transmission rates were higher than previously estimated (Alland et al., 1994) , concomitantly to the decision by the World Health Organization in 1994 to High-throughput MTC spoligotyping method declare TB a global emergency (Nakajima, 1993) . The recent global expansion of MDR-TB and XDR-TB has renewed calls for new public health-oriented research programmes (Dye & Williams, 2008) and the introduction of more efficient and economical genotyping methods worldwide in mycobacteriology laboratories.
High-throughput multiplexed hybridization techniques are being increasingly developed for molecular diagnostics, molecular epidemiology (Dunbar et al., 2003; Jiang et al., 2006) and environmental studies (Baums et al., 2007) . The recent transfer of the 'spoligotyping' technique to a microbead format (Cowan et al., 2004) provided an opportunity for incorporating this type of assay into our laboratory and promoted a new molecular epidemiological study. Indeed the repetitive and heterogeneic nature of CRISPR loci makes them excellent targets for the development of new and powerful genotyping techniques, whilst major diagnostic genomic targets used for bacterial species identification include probes for 23S and/or 16S rRNA genes (Dunbar, 2006; Mokrousov et al., 2007) .
We found the multiplex microbead-based spoligotyping technique to be versatile and easily implemented and it can be adapted (classical 43 spacers format for Europe, improved 68 spacers format for Asia, simplified 10 spacers format for first-screen genotyping in resource-limited settings). It is well established that molecular epidemiolo- gical studies in high-prevalence settings are more difficult to interpret and to run than in low-prevalence settings, requiring more analysis of samples and implementation of complex genotyping schemes. This strongly argues in favour of the widespread adoption of high-throughput methods (Hanekom et al., 2008) .
Further developments in this system will include study of other epidemiologically important clades (such as Beijing) and development of links to SNP-based typing methods allowing clinical, phylogenetic and epidemiological improvements in rapid molecular methods with the aim of providing simultaneous strain typing and molecular antibiogrammes to further aid in control regimens aimed against MDR and XDR-TB.
In conclusion the suspension microarray spoligotyping assay was efficiently implemented, improved and represents a viable and practical alternative to MIRU-VNTR as a first screen for large population-based systematic genotyping programs. An international multicentred project is currently ongoing to confirm our results on a larger scale.
